Abbott Laboratories: Organic Growth Will Carry It Through [Seeking Alpha]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Seeking Alpha
Tim BoyleInvestment ThesisAbbott Laboratories (NYSE:ABTcurrent price against our fair valuation. The company kept on a fast pace in innovation with cross-industry applications. These efforts, along with secular growth in the medical service and products market, will bring continuous growth to the company. It is a buy at the current price for the long term.Company OverviewAbbott Laboratories, an Illinois company incorporated in 1900, has a main focus on discovering, developing, manufacturing, and sale of a broad and diversified line of healthcare products. It has reportable segments in the following four categories: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.StrengthAbbott Laboratories has an encompassing portfolio in health and medical services. The company has an emphasis on treating ongoing cardiovascular issues, and chronic pain in neuromodulation and diabetes, as well as in preventive care of nutritional and diagnostics and
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Royal Bank of Canada from $128.00 to $125.00. They now have an "outperform" rating on the stock.MarketBeat
- Abbott Laboratories (NYSE:ABT) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories First Quarter 2024 Earnings: EPS Beats Expectations [Yahoo! Finance]Yahoo! Finance
- Weight Management Supplement Market Set to Soar at 14.2% CAGR through 2034 Amid Rising Prevalence of Obesity Globally | Future Market Insights, Inc. [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/17/24 - Beat
ABT
Sec Filings
- 4/17/24 - Form 8-K
- 4/2/24 - Form 4
- 4/2/24 - Form 4
- ABT's page on the SEC website